SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030491
Filing Date
2021-07-28
Accepted
2021-07-28 21:18:04
Documents
2
Period of Report
2021-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8618
2 EX-24 DOCUMENT attachment1.htm EX-24 4995
  Complete submission text file 0000899243-21-030491.txt   14992
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208 SEATTLE WA 98102
Business Address
Simpson Adam K. (Reporting) CIK: 0001873839 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40655 | Film No.: 211124512